glp‑1 longevity study
Glp-1 / Weight-Loss Drugs Deliver 20% Mortality Cut
GLP-1 weight-loss drugs cut all-cause mortality by about 20% over five years, according to the latest randomized trial. The study enrolled thousands of adults with obesity and type 2 diabetes, tracking deaths, heart events, and functional decline. These findings suggest a medication could serve as a longevity passport. Medical Disclaimer: